Laboratory Corporation of America Holdings banner

Laboratory Corporation of America Holdings
XBER:LAB

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
XBER:LAB
Watchlist
Price: 195 EUR -0.26% Market Closed
Market Cap: €18.7B

Intrinsic Value

The intrinsic value for Laboratory Corporation of America Holdings (LAB) under the Base Case is 209.94 EUR. Compared with the current market price of 195 EUR, the stock appears Undervalued by 7% .

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

LAB Intrinsic Value
209.94 EUR
Undervaluation 7%
Intrinsic Value
Price €195
Bear Case
Base Case
Bull Case
Monitor LAB
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €167.95
Get notified when the price drops into your buy zone
Intrinsic Value €209.94
Current Price €195
Margin of Safety 20% €167.95
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about LAB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LAB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Laboratory Corporation of America Holdings.

Explain Valuation
Alternatives to LAB

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one LAB stock?

The intrinsic value for Laboratory Corporation of America Holdings (LAB) under the Base Case is 209.94 EUR.

Is LAB stock undervalued or overvalued?

Compared with the current market price of 195 EUR, the stock appears Undervalued by 7% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett